Merkel cell carcinoma : Treatment and outcomes
The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery...
Saved in:
Published in | Cancer Vol. 104; no. 8; pp. 1761 - 1764 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Wiley-Liss
15.10.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent.
Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs).
The 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication.
Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant. |
---|---|
AbstractList | The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent.
Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs).
The 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication.
Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant. BACKGROUNDThe purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent.METHODSBetween October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs).RESULTSThe 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication.CONCLUSIONSPatients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant. Abstract BACKGROUND The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent. METHODS Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow‐up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow‐up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs). RESULTS The 5‐year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause‐specific survival, 52%; and survival, 37%. No patient experienced a severe complication. CONCLUSIONS Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant. Cancer 2005. © 2005 American Cancer Society. Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. The dominant site of failure is distant. |
Author | MCAFEE, William J MENDENHALL, Charles M MORRIS, Christopher G MENDENHALL, Nancy Price MENDENHALL, William M WERNING, John W |
Author_xml | – sequence: 1 givenname: William J surname: MCAFEE fullname: MCAFEE, William J organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States – sequence: 2 givenname: Christopher G surname: MORRIS fullname: MORRIS, Christopher G organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States – sequence: 3 givenname: Charles M surname: MENDENHALL fullname: MENDENHALL, Charles M organization: Department of Radiation Oncology, Phoebe Putney Memorial Hospital, Albany, Georgia, United States – sequence: 4 givenname: John W surname: WERNING fullname: WERNING, John W organization: Department gf Otolaryngology, University of Florida College of Medicine, Gainesville, Florida, United States – sequence: 5 givenname: Nancy Price surname: MENDENHALL fullname: MENDENHALL, Nancy Price organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States – sequence: 6 givenname: William M surname: MENDENHALL fullname: MENDENHALL, William M organization: Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17160012$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16136596$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkMtKxEAQRRsZcR668QMkG10IidXvxJ0MvmDEzQjuQqcfEE06Y3ey8O_NOIHZVFFwuLc4SzTznbcIXWLIMAC5016HjGDK-QlaYChkCpiRGVoAQJ5yRj_naBnj13hKwukZmmOBqeCFWKDszYZv2yTaNuNQQde-a1Vyn2yDVX1rfZ8ob5Ju6HXX2niOTp1qor2Y9gp9PD1u1y_p5v35df2wSTWRrE8rrUEWYztnppKFyivCSC4oLyjVhSTGOWGAVE7Q3DjgVFfWYe6cpIZpwHSFbg65u9D9DDb2ZVvH_Y_K226IpciFxCJnI3h7AHXoYgzWlbtQtyr8lhjKvZ1yb6f8tzPCV1PqULXWHNFJxwhcT4CKWjUuKK_reOTGTgBM6B92IW06 |
CODEN | CANCAR |
Cites_doi | 10.1002/cncr.21979 10.1200/JCO.2000.18.12.2493 10.1016/0360-3016(90)90484-2 10.1097/00005537-200405000-00023 10.1001/archotol.1984.00800370009002 10.1136/jcp.54.9.727 10.1097/00006534-200210000-00007 10.1001/archsurg.1991.01410360088014 10.1002/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8 10.1007/s10434-001-0204-4 10.1016/0360-3016(92)90975-N 10.1001/archderm.1972.01620040075020 10.1200/JCO.2002.20.2.588 10.1016/0360-3016(94)E0145-A |
ContentType | Journal Article |
Copyright | 2005 INIST-CNRS Copyright 2005 American Cancer Society |
Copyright_xml | – notice: 2005 INIST-CNRS – notice: Copyright 2005 American Cancer Society |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/cncr.21355 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0142 |
EndPage | 1764 |
ExternalDocumentID | 10_1002_cncr_21355 16136596 17160012 |
Genre | Multicenter Study Journal Article |
GroupedDBID | --- -~X .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AAQOH AARRQ AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AGNAY AHBTC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C1A C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HF~ HGLYW HHY HHZ HZ~ H~9 IH2 IQODW IX1 J0M J5H JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NEJ NF~ NNB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RSU RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y VH1 W8V W99 WBKPD WH7 WHG WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Y6R YQJ Z0Y ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c274t-bcc07900854db79a8b2428635933c972dff6d02bf638df053cbef15ff73d4c013 |
ISSN | 0008-543X |
IngestDate | Fri Aug 16 10:42:11 EDT 2024 Fri Aug 23 02:13:01 EDT 2024 Sat Sep 28 07:49:57 EDT 2024 Tue Sep 17 11:18:06 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Cancerology Carcinoma Prognosis Treatment treatment outcomes Merkel cell carcinoma Merkel cell Malignant tumor Radiotherapy |
Language | English |
License | CC BY 4.0 Copyright 2005 American Cancer Society |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c274t-bcc07900854db79a8b2428635933c972dff6d02bf638df053cbef15ff73d4c013 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16136596 |
PQID | 68671684 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_68671684 crossref_primary_10_1002_cncr_21355 pubmed_primary_16136596 pascalfrancis_primary_17160012 |
PublicationCentury | 2000 |
PublicationDate | 2005-10-15 |
PublicationDateYYYYMMDD | 2005-10-15 |
PublicationDate_xml | – month: 10 year: 2005 text: 2005-10-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Cancer |
PublicationTitleAlternate | Cancer |
PublicationYear | 2005 |
Publisher | Wiley-Liss |
Publisher_xml | – name: Wiley-Liss |
References | e_1_2_5_13_2 e_1_2_5_16_2 e_1_2_5_8_2 American Joint Committee on Cancer (e_1_2_5_12_2) 2002 e_1_2_5_15_2 e_1_2_5_7_2 e_1_2_5_10_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_4_2 e_1_2_5_11_2 e_1_2_5_3_2 e_1_2_5_2_2 Leonard JH (e_1_2_5_9_2) 2000; 24 e_1_2_5_18_2 e_1_2_5_17_2 SAS Institute Inc. (e_1_2_5_14_2) 2003 |
References_xml | – ident: e_1_2_5_15_2 doi: 10.1002/cncr.21979 – ident: e_1_2_5_18_2 doi: 10.1200/JCO.2000.18.12.2493 – volume-title: SAS OnlineDoc(r) version 9 year: 2003 ident: e_1_2_5_14_2 contributor: fullname: SAS Institute Inc. – ident: e_1_2_5_6_2 doi: 10.1016/0360-3016(90)90484-2 – ident: e_1_2_5_17_2 doi: 10.1097/00005537-200405000-00023 – ident: e_1_2_5_5_2 doi: 10.1001/archotol.1984.00800370009002 – ident: e_1_2_5_10_2 doi: 10.1136/jcp.54.9.727 – ident: e_1_2_5_4_2 doi: 10.1097/00006534-200210000-00007 – volume: 24 start-page: 620 year: 2000 ident: e_1_2_5_9_2 article-title: Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma publication-title: Cancer Detect Prev. contributor: fullname: Leonard JH – ident: e_1_2_5_13_2 doi: 10.1001/archsurg.1991.01410360088014 – volume-title: AJCC cancer staging manual year: 2002 ident: e_1_2_5_12_2 contributor: fullname: American Joint Committee on Cancer – ident: e_1_2_5_11_2 doi: 10.1002/1097-0142(20010915)92:6<1650::AID-CNCR1491>3.0.CO;2-8 – ident: e_1_2_5_7_2 doi: 10.1007/s10434-001-0204-4 – ident: e_1_2_5_16_2 doi: 10.1016/0360-3016(92)90975-N – ident: e_1_2_5_2_2 doi: 10.1001/archderm.1972.01620040075020 – ident: e_1_2_5_3_2 doi: 10.1200/JCO.2002.20.2.588 – ident: e_1_2_5_8_2 doi: 10.1016/0360-3016(94)E0145-A |
SSID | ssj0007253 |
Score | 2.1796405 |
Snippet | The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with... Abstract BACKGROUND The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who... BACKGROUNDThe purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 1761 |
SubjectTerms | Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use Biological and medical sciences Carcinoma, Merkel Cell - drug therapy Carcinoma, Merkel Cell - radiotherapy Carcinoma, Merkel Cell - surgery Carcinoma, Merkel Cell - therapy Chemotherapy, Adjuvant Combined Modality Therapy Female Humans Male Medical sciences Middle Aged Skin Neoplasms - drug therapy Skin Neoplasms - radiotherapy Skin Neoplasms - surgery Skin Neoplasms - therapy Survival Rate Treatment Outcome Tumors |
Title | Merkel cell carcinoma : Treatment and outcomes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16136596 https://search.proquest.com/docview/68671684 |
Volume | 104 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSAgJofE1CmxEgjeU0jhubPNWbZkKaopUOrG3KHZsaQLSqU1f-Os5fzRepk18vERt1Cbt3eX8u_Pd7xB6xygEySPJ40zWLIYVmsdCKh0nRFY2HmDKpAaKeTY9I5_Px-dhvJXtLmnFUP66sa_kf7QK50Cvpkv2HzTbXRROwGvQLxxBw3D8Kx0Xav1d_Xhvku-GYlpeNKuflQ3yl7368dW2hdv7asFASyBDZW5xPDnNbWGkT8CE7aLiy2Lx6es1IoIwkqvI5yf5fDqZza7s3occ67d8Mfd9Ua5Ip5dmsPSkrtEyOLN4drHZ9Lwpi8fEzvMN3tRNE_Zmw674xoQ62nW_zsJbcqMPd5ywspHrIU5SR-LbJ8q-toB1ZYWG-sfgt7voHga_Y3ftF4FNjGJPSup_dsdWiz-Eu_XwycPLagOPinYzTm4PQiwYWe6jRz6KiCbOJB6jO6p5gu4Xvk7iKRo6y4iMZUSdZUQfo84uIrCLaGcXz9DZab48nsZ-MkYsMSUtPE5yRLmBy6QWlFdMANJigB15mkpOca11Vo-w0OBdaw1-Vgqlk7HWNK2JBNT_HO01q0a9QFHCxUinVCU1gHdK0wqzWgGoTAThKSCXAXq7k0d56QhQSkd1jUsjtdJKbYCOeqIKH_UqGaA3O9mV4MDM368atdpuyswwLGaMDNCBE2n4bmZqMHn28k8Xf4UeBJN9jfba9VYdAlZsxZG1gN-Tv2St |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Merkel+cell+carcinoma+%3A+Treatment+and+outcomes&rft.jtitle=Cancer&rft.au=MCAFEE%2C+William+J&rft.au=MORRIS%2C+Christopher+G&rft.au=MENDENHALL%2C+Charles+M&rft.au=WERNING%2C+John+W&rft.date=2005-10-15&rft.pub=Wiley-Liss&rft.issn=0008-543X&rft.volume=104&rft.issue=8&rft.spage=1761&rft.epage=1764&rft_id=info:doi/10.1002%2Fcncr.21355&rft.externalDBID=n%2Fa&rft.externalDocID=17160012 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |